Angiotensin II type 1 and 2 receptors in conduit arteries of normal developing microswine.
OBJECTIVE
To identify vascular cells capable of responding to angiotensin II (Ang II) generated in conduit arteries, we examined the Ang II type 1 receptor (AT1R) and Ang II type 2 receptor (AT2R) in the thoracic aorta (TA) and abdominal aorta (AA) and branches in 90-day fetal, 3-week postnatal, and 6-month adult microswine.


RESULTS
By autoradiography ((125)I-[Sar(1)Ile(8)]-Ang II with or without AT1R- or AT2R-selective analogues or (125)I-CGP 42112), there were striking rostrocaudal differences in (1) AT2R binding at all ages (prominent in AA wall and branches, sparse in TA wall and branches) and (2) a non-AT2R binding site for CGP 42112 (consistently evident in postnatal TA and branches but absent in AA and branches). Furthermore, patterns of AT2R distribution in infradiaphragmatic arteries were developmentally distinct. In fetal AAs, high-density AT2Rs occupied the inner 60% of the medial-endothelial wall. In postnatal AAs, AT2Rs were sparse in the medial-endothelial wall but prominent in a circumferential smooth muscle alpha-actin-negative cell layer at the medial-adventitial border, occupying approximately 20% to 25% of the AA cross-sectional area. AT1R density in the TA and AA medial-endothelial wall increased with age, whereas AT2R density decreased after birth.


CONCLUSIONS
A novel AT2R-positive cell layer confined to postnatal infradiaphragmatic arteries physically links adventitial and medial layers, appears optimally positioned to transduce AT2R-dependent functions of local Ang II, and suggests that adventitial Ang II may elicit regionally distinct vascular responses.
Department of Medicine, Oregon Health and Science University and Portland VA Medical Center, USA.
Susan P
SP
Bagby
Linda S
LS
LeBard
Zaiming
Z
Luo
Robert C
RC
Speth
Bryan E
BE
Ogden
Christopher L
CL
Corless
D000199:Actins / Q000378:metabolism; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000378:metabolism; D047228:Angiotensin II Type 1 Receptor Blockers; D057912:Angiotensin II Type 2 Receptor Blockers; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000831:Animals, Newborn / Q000097:blood; D001012:Aorta, Abdominal / Q000737:chemistry* / Q000378:metabolism* / Q000502:physiology; D001013:Aorta, Thoracic / Q000737:chemistry* / Q000378:metabolism* / Q000502:physiology; D001345:Autoradiography; D001665:Binding Sites; D005333:Fetus / Q000098:blood supply; D007457:Iodine Radioisotopes / Q000032:analysis; D008566:Membranes / Q000737:chemistry / Q000378:metabolism; D009130:Muscle, Smooth / Q000737:chemistry / Q000196:embryology / Q000378:metabolism; D009842:Oligopeptides / Q000032:analysis; D011869:Radioligand Assay; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin / Q000378:metabolism*; D013552:Swine; D013556:Swine, Miniature / Q000097:blood / Q000196:embryology; D017540:Tunica Media / Q000737:chemistry / Q000196:embryology / Q000378:metabolism
D000199:Actins; D047228:Angiotensin II Type 1 Receptor Blockers; D057912:Angiotensin II Type 2 Receptor Blockers; D057911:Angiotensin Receptor Antagonists; D007457:Iodine Radioisotopes; D009842:Oligopeptides; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin; D000804:Angiotensin II; C060894:CGP 42112A